Search

everythinglearnresearchcommunity

for

Search:↓

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

c-kit affects hair growth and color in alopecia areata and androgenetic alopecia.

People with alopecia have shorter hair follicles and more c-kit, a stem cell factor receptor, which could predict how the condition progresses.

Decorin, a protein, may help start hair growth and could be used to treat hair loss.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

Oxytocin receptors are found in skin cells near touch and pain neurons.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

Blue-light activation of TrkA improves hair-follicle stem cells' ability to become neurons and glial cells.

ERG increases SOX9, promoting prostate cancer growth and invasion.

Epidermal stem cells are diverse and vary in activity, playing key roles in skin maintenance and repair.

Beta-caryophyllene helps improve wound healing in mice, especially in females.

Beta-caryophyllene, found in essential oils, helps wounds heal better in multiple ways.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

The extract of Silybum marianum, Manganese PCA, and Lespedeza capitata can boost hair growth and extend the growth phase when combined in a serum.

Silybum marianum extract, Manganese PCA, and Lespedeza capitata extract may help with hair growth and anchorage, potentially aiding in hair loss treatment.

Skin reactions from cancer treatments might predict how well the treatments work.

Dexpanthenol helps human hair follicle cells grow by preventing aging and death, and by supporting growth signals.

High levels of ERK activity are key for tissue regeneration in spiny mice, and activating ERK can potentially redirect scar-forming healing towards regenerative healing in mammals.

A 15-year-old girl with no menstrual period was diagnosed with a genetic condition that makes her body unable to respond to male hormones, leading to female characteristics despite having male genetic makeup.

EGFR helps control how hair grows and forms without needing p53 protein.

A protein called desmoglein 3 is important for keeping hair follicle stem cells inactive and helps in their regeneration.